
Scientists from Bristol-Myers Squibb have launched their elective course as part of the Rutgers Toxicology training program. This course aims to provide students and postdocs with an understanding of the drug discovery and development paradigm, from target validation and lead optimization to the numerous preclinical studies conducted to ensure drug safety. Scientists will describe the […]